Data

A Strategy of High-Dose Lenalidomide in Combination with Epigenetic Therapies for Relapsed or Refractory Acute Myeloid Leukaemia (AML)- Phase II (AMLM17)

Health Data Australia Contributor Records
Wei, Andrew ; Australasian Leukaemia And Lymphoma Group (ALLG) ; Australasian Leukaemia And Lymphoma Group (ALLG)
Viewed: [[ro.stat.viewed]] Cited: [[ro.stat.cited]] Accessed: [[ro.stat.accessed]]
ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rfr_id=info%3Asid%2FANDS&rft_id=info:doi10.58109/3VA6-FR14&rft.title=A Strategy of High-Dose Lenalidomide in Combination with Epigenetic Therapies for Relapsed or Refractory Acute Myeloid Leukaemia (AML)- Phase II (AMLM17)&rft.identifier=http://doi.org/10.58109/3VA6-FR14&rft.publisher=Australasian Leukaemia and Lymphoma Group (ALLG)&rft.description=Dataset includes: Data for 20 refractory AML patients Lenalidomide given at relapse of disease Demographic data, diagnostic, treatment data, outcome data Disease and disease response measurements Close monitoring of response to drug Pathology design data Clinical outcome measurements&rft.creator=Wei, Andrew &rft.creator=Australasian Leukaemia And Lymphoma Group (ALLG) &rft.creator=Australasian Leukaemia And Lymphoma Group (ALLG) &rft.date=2023&rft.relation=https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12612000312842&rft_subject=Chemotherapy&rft.type=dataset&rft.language=English Access the data
Cite Saved to MyRDA Save to MyRDA

Full description

Dataset includes: Data for 20 refractory AML patients Lenalidomide given at relapse of disease Demographic data, diagnostic, treatment data, outcome data Disease and disease response measurements Close monitoring of response to drug Pathology design data Clinical outcome measurements

Notes

HeSANDA 1.0.0

Issued: 2023

This dataset is part of a larger collection

Click to explore relationships graph
Help

Related Publications

Related Organisations

Related People

Subjects
Chemotherapy |

User Contributed Tags    

Login to tag this record with meaningful keywords to make it easier to discover

Other Information
Australasian Leukaemia And Lymphoma Group (ALLG)

ORCID : https://orcid.org/0000-0002-7514-3298

Australasian Leukaemia And Lymphoma Group (ALLG)

ROR : https://ror.org/05t72y326

Australasian Leukaemia and Lymphoma Group (ALLG)

ROR : https://ror.org/05t72y326

Identifiers
Similar data you may be interested in: